Unveiling the molecular features, relevant immune and clinical characteristics of SIGLEC15 in thyroid cancer

The groundbreaking research work about SIGLEC15 has raised it as a potential promising target in cancer immunotherapy. Unfortunately, the role of SIGLEC15 in thyroid carcinoma (THCA) remains obscure. Public and home multi-omics data were collected to investigate the role of SIGLEC15 in THCA in our s...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Xiaofeng, Chen, Chao, Lan, Xiabin, He, Xiaodong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500188/
https://www.ncbi.nlm.nih.gov/pubmed/36159823
http://dx.doi.org/10.3389/fimmu.2022.975787

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9500188/
https://www.ncbi.nlm.nih.gov/pubmed/36159823
http://dx.doi.org/10.3389/fimmu.2022.975787

Ejemplares similares